Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Elvitegravir> ?p ?o }
- Elvitegravir abstract "Elvitegravir (EVG, formerly GS-9137) is an integrase inhibitor used to treat HIV infection. It was developed by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012 for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild. On September 24, 2014 the FDA approved Elvitegravir (tradename Vitekta) as a single pill formulation. On November 5, 2015 the FDA approved the drug for use in patients affected with HIV-1 as a part of a second fixed dose combination pill known as Genvoya.According to the results of the phase II clinical trial, patients taking once-daily elvitegravir boosted by ritonavir had greater reductions in viral load after 24 weeks compared to individuals randomized to receive a ritonavir-boosted protease inhibitor.".
- Elvitegravir atcPrefix "J05".
- Elvitegravir atcSuffix "AX11".
- Elvitegravir casNumber "697761-98-1".
- Elvitegravir chEBI "72289".
- Elvitegravir fdaUniiCode "4GDQ854U53".
- Elvitegravir iupacName "6-[(3-Chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid".
- Elvitegravir pubchem "5277135".
- Elvitegravir thumbnail Elvitegravir_structure.svg?width=300.
- Elvitegravir wikiPageID "14767972".
- Elvitegravir wikiPageLength "6521".
- Elvitegravir wikiPageOutDegree "20".
- Elvitegravir wikiPageRevisionID "700894893".
- Elvitegravir wikiPageWikiLink CYP3A.
- Elvitegravir wikiPageWikiLink Category:Chloroarenes.
- Elvitegravir wikiPageWikiLink Category:Integrase_inhibitors.
- Elvitegravir wikiPageWikiLink Category:Japan_Tobacco.
- Elvitegravir wikiPageWikiLink Category:Organofluorides.
- Elvitegravir wikiPageWikiLink Category:Quinolines.
- Elvitegravir wikiPageWikiLink Combination_drug.
- Elvitegravir wikiPageWikiLink Discovery_and_development_of_integrase_inhibitors.
- Elvitegravir wikiPageWikiLink tenofovir.
- Elvitegravir wikiPageWikiLink Food_and_Drug_Administration.
- Elvitegravir wikiPageWikiLink Gilead_Sciences.
- Elvitegravir wikiPageWikiLink HIV.
- Elvitegravir wikiPageWikiLink Japan_Tobacco.
- Elvitegravir wikiPageWikiLink Protease_inhibitor_(pharmacology).
- Elvitegravir wikiPageWikiLink Ritonavir.
- Elvitegravir wikiPageWikiLink Viral_load.
- Elvitegravir wikiPageWikiLinkText "Elvitegravir".
- Elvitegravir wikiPageWikiLinkText "Vitekta".
- Elvitegravir wikiPageWikiLinkText "elvitegravir".
- Elvitegravir atcPrefix "J05".
- Elvitegravir atcSuffix "AX11".
- Elvitegravir c "23".
- Elvitegravir casNumber "697761".
- Elvitegravir chebi "72289".
- Elvitegravir chembl "204656".
- Elvitegravir chemspiderid "4441060".
- Elvitegravir cl "1".
- Elvitegravir eliminationHalfLife "46440.0".
- Elvitegravir excretion "liver 93%, renal 7%".
- Elvitegravir f "1".
- Elvitegravir h "23".
- Elvitegravir image "Elvitegravir3D.PNG".
- Elvitegravir inchi "1".
- Elvitegravir inchikey "JUZYLCPPVHEVSV-LJQANCHMBZ".
- Elvitegravir iupacName "6".
- Elvitegravir metabolism "liver, via CYP3A".
- Elvitegravir molecularWeight "447.883".
- Elvitegravir n "1".
- Elvitegravir niaidChemdb "241767".
- Elvitegravir o "5".
- Elvitegravir pregnancyUs "B".
- Elvitegravir proteinBound "98.0".
- Elvitegravir pubchem "5277135".
- Elvitegravir routesOfAdministration "oral".
- Elvitegravir smiles "Clc1ccccCc3ccc2cc3".
- Elvitegravir stdinchi "1".
- Elvitegravir stdinchikey "JUZYLCPPVHEVSV-LJQANCHMSA-N".
- Elvitegravir tradename tenofovir.
- Elvitegravir unii "4".
- Elvitegravir verifiedfields "changed".
- Elvitegravir verifiedrevid "437144022".
- Elvitegravir watchedfields "changed".
- Elvitegravir wikiPageUsesTemplate Template:Cascite.
- Elvitegravir wikiPageUsesTemplate Template:Chemspidercite.
- Elvitegravir wikiPageUsesTemplate Template:Drugbox.
- Elvitegravir wikiPageUsesTemplate Template:Ebicite.
- Elvitegravir wikiPageUsesTemplate Template:Fdacite.
- Elvitegravir wikiPageUsesTemplate Template:HIVpharm.
- Elvitegravir wikiPageUsesTemplate Template:Reflist.
- Elvitegravir wikiPageUsesTemplate Template:Stdinchicite.
- Elvitegravir subject Category:Chloroarenes.
- Elvitegravir subject Category:Integrase_inhibitors.
- Elvitegravir subject Category:Japan_Tobacco.
- Elvitegravir subject Category:Organofluorides.
- Elvitegravir subject Category:Quinolines.
- Elvitegravir hypernym Inhibitor.
- Elvitegravir type ChemicalSubstance.
- Elvitegravir type Company.
- Elvitegravir type Drug.
- Elvitegravir type Company.
- Elvitegravir type Drug.
- Elvitegravir type Heterocycle.
- Elvitegravir type Inhibitor.
- Elvitegravir type Organofluoride.
- Elvitegravir type Organohalide.
- Elvitegravir type Redirect.
- Elvitegravir type Organofluoride.
- Elvitegravir type Organohalide.
- Elvitegravir type ChemicalObject.
- Elvitegravir type Thing.
- Elvitegravir type Q8386.
- Elvitegravir comment "Elvitegravir (EVG, formerly GS-9137) is an integrase inhibitor used to treat HIV infection. It was developed by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012 for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild.".
- Elvitegravir label "Elvitegravir".
- Elvitegravir sameAs Q2740966.
- Elvitegravir sameAs إلفيتغرافير.
- Elvitegravir sameAs Elvitegraviiri.
- Elvitegravir sameAs Elvitégravir.